$25.68
+0.18 (+0.71%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+291.4% upside
Low Target
$77.00
Average Target
$100.50
High Target
$121.27
Current Price
$25.68
Current
$25.68
$25.68
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Scenario Analysis
Bear Case
$77.00
199.8%
Low target
Base Case
$100.50
+291.4%
Avg target
Bull Case
$121.27
+372.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$28.72
-10.6% from high
52-Week Low
$7.06
+263.7% from low
50-Day SMA
$22.13
+16.0% vs SMA
200-Day SMA
$15.14
+69.6% vs SMA
RSI (14)
36.6
Neutral
Target vs 52W High
$100.50
+249.9% vs high
Next Earnings Report
May 12, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.89
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 72% | $257.58 | +27.8% |
| AMGN | Hold | 43 | 49% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 26 | 96% | $143.40 | +41.5% |